Variant report
Variant | esv3354803 |
---|---|
Chromosome Location | chr7:64411417-64415915 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:64404479..64405993-chr7:64410374..64412300,2 | K562 | blood: | |
2 | chr7:64415881..64418431-chr7:64455784..64458339,2 | K562 | blood: | |
3 | chr7:64411695..64412275-chr7:64772412..64772922,2 | K562 | blood: | |
4 | chr7:64414429..64416798-chr7:64452211..64454777,2 | MCF-7 | breast: | |
5 | chr7:64407101..64409765-chr7:64410479..64412336,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6978473 | chr7:64411470-64411471 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs566783226 | chr7:64411478-64411479 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532141086 | chr7:64411514-64411515 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376146618 | chr7:64411533-64411534 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144846824 | chr7:64411613-64411614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192205063 | chr7:64411626-64411627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184368809 | chr7:64411664-64411665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188764195 | chr7:64411728-64411729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113981714 | chr7:64411730-64411731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79753110 | chr7:64411796-64411797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534131910 | chr7:64411806-64411807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534933302 | chr7:64411881-64411882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77455903 | chr7:64411919-64411920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577167127 | chr7:64411923-64411924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545784936 | chr7:64411939-64411940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114885485 | chr7:64411966-64411967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62455631 | chr7:64411993-64411994 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541930345 | chr7:64412046-64412047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559984371 | chr7:64412051-64412052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562227237 | chr7:64412066-64412067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200120807 | chr7:64412162-64412163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529811781 | chr7:64412173-64412174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62455632 | chr7:64412239-64412240 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs148574672 | chr7:64412241-64412242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142796940 | chr7:64412252-64412253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74657877 | chr7:64412322-64412323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150626353 | chr7:64412323-64412324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531350822 | chr7:64412348-64412349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558545636 | chr7:64412364-64412365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547934801 | chr7:64412404-64412405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568149170 | chr7:64412405-64412406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534125215 | chr7:64412416-64412417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553988254 | chr7:64412445-64412446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570797119 | chr7:64412450-64412451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191665432 | chr7:64412472-64412473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556838257 | chr7:64412527-64412528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572285573 | chr7:64412556-64412557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538823219 | chr7:64412591-64412592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576323837 | chr7:64412594-64412595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542217558 | chr7:64412595-64412596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76517163 | chr7:64412632-64412633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184689077 | chr7:64412643-64412644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140017435 | chr7:64412663-64412664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577885082 | chr7:64412667-64412668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7781025 | chr7:64412711-64412712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs189574630 | chr7:64412743-64412744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577133455 | chr7:64412800-64412801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540905278 | chr7:64412831-64412832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143728183 | chr7:64412914-64412915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562807794 | chr7:64412917-64412918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Glioblastoma | 21080181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Schizophrenia | 20967226 | CNVD |
Cancer | 21272361 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:64408800-64412800 | Weak transcription | HepG2 | liver |
2 | chr7:64409200-64412800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr7:64411200-64412000 | Enhancers | Adipose Nuclei | Adipose |
4 | chr7:64411400-64411600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr7:64411400-64411600 | Enhancers | Fetal Heart | heart |
6 | chr7:64411400-64411600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
7 | chr7:64411400-64419000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr7:64411600-64411800 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
9 | chr7:64411800-64412000 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr7:64412000-64412800 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr7:64412800-64413000 | Enhancers | Adipose Nuclei | Adipose |
12 | chr7:64412800-64413200 | Enhancers | HepG2 | liver |
13 | chr7:64412800-64413400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr7:64413000-64419800 | Weak transcription | Adipose Nuclei | Adipose |